TC
VRTX icon

TownSquare Capital’s Vertex Pharmaceuticals VRTX Stock Holding History

TownSquare Capital’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$541K Buy
1,090
+19
+2% +$8.42K 0.1% 166
2026
Q1 		$478K Buy
1,071
+64
+6% +$29.8K 0.11% 155
2025
Q4 		$457K Buy
1,007
+152
+18% +$65.5K 0.1% 158
2025
Q3 		$335K Sell
855
-1,612
-65% -$674K 0.05% 268
2025
Q2 		$1.1M Sell
2,467
-20,519
-89% -$9.46M 0.11% 180
2025
Q1 		$11.1M Buy
22,986
+5,859
+34% +$2.73M 0.12% 161
2024
Q4 		$6.9M Buy
17,127
+2,073
+14% +$961K 0.08% 231
2024
Q3 		$7M Buy
15,054
+3,616
+32% +$1.74M 0.08% 237
2024
Q2 		$5.36M Buy
11,438
+1,948
+21% +$846K 0.07% 250
2024
Q1 		$3.97M Buy
9,490
+714
+8% +$302K 0.06% 302
2023
Q4 		$3.57M Sell
8,776
-6,124
-41% -$2.26M 0.06% 296
2023
Q3 		$5.18M Buy
14,900
+1,829
+14% +$640K 0.09% 208
2023
Q2 		$4.6M Buy
13,071
+5,927
+83% +$2M 0.08% 219
2023
Q1 		$2.25M Sell
7,144
-188
-3% -$56.4K 0.05% 305
2022
Q4 		$2.12M Buy
7,332
+1,300
+22% +$396K 0.05% 294
2022
Q3 		$1.75M Buy
6,032
+770
+15% +$222K 0.05% 282
2022
Q2 		$1.48M Buy
5,262
+1,581
+43% +$423K 0.04% 289
2022
Q1 		$961K Buy
3,681
+491
+15% +$117K 0.02% 354
2021
Q4 		$701K Buy
3,190
+1,233
+63% +$240K 0.02% 416
2021
Q3 		$355K Buy
+1,957
New +$382K 0.01% 519

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

TownSquare Capital's VRTX Position: Q2 2026 in Review

TownSquare Capital increased its Vertex Pharmaceuticals (VRTX) stake by 1.8% in Q2 2026, buying an estimated $8.42K and bringing the position to 1,090 shares worth $541K. The position accounts for 0.1% of the portfolio, ranked #166.

TownSquare Capital first reported a position in VRTX in Q3 2021 and has held it in 20 quarters since. The position peaked at $11.1M in Q1 2025. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • TownSquare Capital held 1,090 shares of Vertex Pharmaceuticals worth $541K as of Q2 2026.
  • TownSquare Capital bought 19 Vertex Pharmaceuticals shares in Q2 2026, an estimated $8.42K.
  • Vertex Pharmaceuticals made up 0.1% of TownSquare Capital's portfolio in Q2 2026, its #166 holding.
  • TownSquare Capital first reported a position in Vertex Pharmaceuticals in Q3 2021 and has held it in 20 quarters since.
  • TownSquare Capital's Vertex Pharmaceuticals position peaked at $11.1M in Q1 2025.
  • 1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on TownSquare Capital's 13F filing for Q2 2026, filed 14 Aug 2026.